<h3>申请 TipRanks 高级版 50% 折扣</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
<p>IVD Medical Holding Limited (HK:1931) 提供了最新动态。</p>
<p>ETHK Labs Inc. 宣布了其董事会的当前组成，任命了三名执行董事、两名非执行董事和三名独立非执行董事，包括总经理和首席科学家等职务。公司还详细说明了其审计、薪酬和提名委员会的成员和领导结构，独立非执行董事张建雷担任三者的主席，表明其治理结构强调独立监督和董事会内职责的明确分配。</p>
<p>最近对 (HK:1931) 股票的分析师评级为持有，目标价格为 HK$1.50。要查看 IVD Medical Holding Limited 股票的完整分析师预测列表，请参见 HK:1931 股票预测页面。</p>
<p><strong>关于 IVD Medical Holding Limited 的更多信息</strong></p>
<p>ETHK Labs Inc. 注册于开曼群岛，并在香港以股票代码 1931 上市，董事会由执行董事、非执行董事和独立非执行董事组成。董事会结构反映了典型的香港上市公司治理框架，设有专门委员会负责审计、薪酬和提名职能，以支持监督和合规。</p>
<p><strong>平均交易量：</strong> 3,898,399</p>
<p><strong>技术情绪信号：</strong> 卖出</p>
<p><strong>当前市值：</strong> HK$2.11B</p>

华检医疗

<p>ETHK LABS INC. 宣布了其董事会组成，包括三名执行董事、两名非执行董事和三名独立非执行董事。独立非执行董事张建雷将担任审计、薪酬和提名委员会的主席，强调独立监督。该公司在香港上市，股票代码为 1931，目前分析师评级为持有，目标价格为 1.50 港元。其治理结构符合香港企业治理标准，支持合规监管</p>

<h3>Claim 50% Off TipRanks Premium</h3>
<div class="lb-trans"><h3>申请 TipRanks 高级版 50% 折扣</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
</div><p>IVD Medical Holding Limited ( (HK:1931) ) has provided an update.</p>
<div class="lb-trans"><p>IVD Medical Holding Limited (HK:1931) 提供了最新动态。</p>
</div><p>ETHK Labs Inc. has announced the current composition of its board of directors, naming three executive directors, two non-executive directors and three independent non-executive directors, including roles such as general manager and chief scientist. The company has also detailed the membership and leadership of its audit, remuneration and nomination committees, with independent non-executive director Zhang Jianlei serving as chairman of all three, signaling a governance structure that emphasizes independent oversight and clear allocation of responsibilities within the board.</p>
<div class="lb-trans"><p>ETHK Labs Inc. 宣布了其董事会的当前组成，任命了三名执行董事、两名非执行董事和三名独立非执行董事，包括总经理和首席科学家等职务。公司还详细说明了其审计、薪酬和提名委员会的成员和领导结构，独立非执行董事张建雷担任三者的主席，表明其治理结构强调独立监督和董事会内职责的明确分配。</p>
</div><p>The most recent analyst rating on (HK:1931) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on IVD Medical Holding Limited stock, see the HK:1931 Stock Forecast page.</p>
<div class="lb-trans"><p>最近对 (HK:1931) 股票的分析师评级为持有，目标价格为 HK$1.50。要查看 IVD Medical Holding Limited 股票的完整分析师预测列表，请参见 HK:1931 股票预测页面。</p>
</div><p><strong>More about IVD Medical Holding Limited</strong></p>
<div class="lb-trans"><p><strong>关于 IVD Medical Holding Limited 的更多信息</strong></p>
</div><p>ETHK Labs Inc., incorporated in the Cayman Islands and listed in Hong Kong under stock code 1931, is governed by a board comprising executive, non-executive and independent non-executive directors. The board structure reflects a typical Hong Kong-listed corporate governance framework, with specialized committees overseeing audit, remuneration and nomination functions to support oversight and regulatory compliance.</p>
<div class="lb-trans"><p>ETHK Labs Inc. 注册于开曼群岛，并在香港以股票代码 1931 上市，董事会由执行董事、非执行董事和独立非执行董事组成。董事会结构反映了典型的香港上市公司治理框架，设有专门委员会负责审计、薪酬和提名职能，以支持监督和合规。</p>
</div><p><strong>Average Trading Volume:</strong> 3,898,399</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 3,898,399</p>
</div><p><strong>Technical Sentiment Signal:</strong> Sell</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 卖出</p>
</div><p><strong>Current Market Cap:</strong> HK$2.11B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> HK$2.11B</p>
</div>

华检医疗确定董事会组成及委员会职能